Provided by Tiger Trade Technology Pte. Ltd.

CMS

10.540
+0.1000.96%
Volume:4.19M
Turnover:43.55M
Market Cap:25.64B
PE:17.13
High:11.000
Open:11.000
Low:10.300
Close:10.440
52wk High:15.088
52wk Low:9.354
Shares:2.43B
HK Float Shares:2.43B
Volume Ratio:2.28
T/O Rate:0.17%
Dividend:0.35
Dividend Rate:3.34%
EPS(LYR):0.615
ROE:8.42%
ROA:5.62%
PB:1.22
PE(LYR):17.13
PS:2.51

Loading ...

Humana is the 'Biggest Winner' From CMS' Medicare Advantage Star Ratings Impact on 2028 Reimbursements, Oppenheimer Says

MT Newswires Live
·
12 hours ago

Lantheus Holdings (LNTH) Gains CMS Reimbursement Win Following A Fair Value Debate

Simply Wall St.
·
Yesterday

Outlook Therapeutics Submits HCPCS Level II Application to CMS for Permanent J-Code for LYTENAVA™ (bevacizumab-vikg)

GlobeNewswire
·
Oct 01

China Medical System Says Singapore Share Transfer Agent to Rename to Ascentium Corporate Services from Oct. 1

Reuters
·
Oct 01

CMS Announces Renaming of Singapore Share Transfer Agent to Ascentium Corporate Services

Bulletin Express
·
Sep 30

CMS Maintains Stable Share Structure in September 2026; Public Float Remains Compliant

Bulletin Express
·
Sep 30

CMS Announces Preliminary Medicare Payment Rates for Laboratory Services in 2027

MT Newswires Live
·
Sep 22

Lazard Asset Management Raises Stake in CMS with 1.265 Million Share Purchase

Deep News
·
Sep 16

China Medical System Gets China Nod for Lupus Erythematosus Drug Trial

MT Newswires
·
Sep 14

CMS Secures Clinical Trial Green Light for Innovative Lupus Treatment Candidate

Stock News
·
Sep 14

China Medical System Holdings - CMS-D001 Granted Drug Clinical Trial Approval Notice by Nmpa on Sept 11, 2026

THOMSON REUTERS
·
Sep 14

CMS: Initial Prescriptions for Silevimig Injection, the World’s First Bispecific Antibody Against Rabies, Issued in China

GlobeNewswire
·
Sep 09

CMS(867.HK/8A8.SG): Innovative Drug Lumirix® Approved in China for Additional Indication of Atopic Dermatitis (AD)

GlobeNewswire
·
Sep 03

CMS’s Dermavon Secures NMPA Green Light for Lumirix® in Mild-to-Moderate Atopic Dermatitis

Bulletin Express
·
Sep 03

CMS Secures NMPA Nod for Ruxolitinib Cream's Expanded Use in Atopic Dermatitis

Stock News
·
Sep 03

China Medical System Holdings Limited Nda for Additional Indication Ad for Ruxolitinib Phosphate Cream Lumirix Approved in China

THOMSON REUTERS
·
Sep 03

China Medical System Wins China Approval for Ruxolitinib Cream in Atopic Dermatitis

Reuters
·
Sep 03

China Medical System Holdings - Dermavon Receives Nmpa Approval for Lumirix Nda for Atopic Dermatitis on Sept 2, 2026

THOMSON REUTERS
·
Sep 03

Fu Pengbo and Zhao Feng's Portfolio Moves Revealed: Hidden Major Holdings in HK Stocks Including CMS, KE Holdings, and Minth Group

Stock News
·
Sep 01

CMS Shifts to Full Electronic Distribution of Corporate Communications

Bulletin Express
·
Sep 01